Newswise — (Kansas City, MO): The Vasculitis Foundation (VF) funded a new one year study led by Renate Kain, MD, from the Medical University of Vienna, Austria. The VF provided the $50,000 award through its Vasculitis Research Program.

The study will involve using novel techniques to fluorescently label LAMP-2 and so provide a unique opportunity to discover whether it also promotes uptake of MPO and PR3 by antigen presenting cells before transporting them into the antigen loading compartment; and also to determine whether anti-LAMP-2 antibodies interfere with the process.

More information about this study can be found at:

This study is one of three protocols funded in 2015 through the VF Research Program, which is supported by donations from supporters.

The Vasculitis Foundation collaborates with researchers around the world to support the most promising vasculitis studies. The purpose of the VF Research Program is to provide one- or two-year seed grants to support pilot studies in quality research to improve the quality of life for patients with vasculitis and ultimately find the cause/s and cure for vasculitis.

Since 1986, the Vasculitis Foundation has empowered patients through disease education, raising awareness of vasculitis in the general public and medical community, and funding research to determine the cause, develop more effective treatments, and discover a cure. The VF is committed to improving the lives of current and future patients and is positioned as the definitive resource for patients, family members, medical professionals and researchers seeking information about vasculitis.

For information about vasculitis and the Vasculitis Foundation visit

Register for reporter access to contact details